Lataa...
Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival
Background: In trials of early two-dose measles vaccination (MV), with the first dose being given before 9 months of age, vaccination in the presence of maternal antibody reduced mortality 2- to 3-fold compared with MV in the presence of no measles antibody. We tested this finding in two historical...
Tallennettuna:
| Julkaisussa: | Front Pediatr |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7020693/ https://ncbi.nlm.nih.gov/pubmed/32117827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2020.00020 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|